ICANEWS

Humanities

Pomegranate Compound Urolithin A Improves Heart Function in Animal Models and Human Tissue

Read research and analysis on Pomegranate Compound Urolithin A Improves Heart Function in Animal Models and Human Tissue published by ICANEWS, a global research

Overview

Research indicates that urolithin A, a compound metabolized from constituents found in pomegranates, walnuts, and certain berries, demonstrated significant improvements in cardiac function. This compound enhanced measures of heart function by up to 80% in animal models affected by a difficult-to-treat form of heart failure. Specific benefits observed included the relaxation of stiff heart tissue, a reduction in scarring, and a decrease in abnormal cardiac enlargement. Furthermore, urolithin A was shown to improve relaxation capabilities in engineered human heart tissue.

Findings

  • Urolithin A improved measures of heart function by up to 80% in animal models of a difficult-to-treat form of heart failure.
  • The compound helped stiff heart tissue relax.
  • Urolithin A reduced scarring in heart tissue.
  • It mitigated abnormal enlargement of heart tissue.
  • Urolithin A improved relaxation in engineered human heart tissue.

Why This Matters

The observed effects of urolithin A in improving heart function, particularly in relaxing stiff heart tissue, reducing scarring, and diminishing abnormal enlargement within animal models of a challenging heart failure type, as well as its positive impact on engineered human heart tissue, suggest potential therapeutic relevance for cardiac health.

Key Findings

  • Urolithin A improved measures of heart function by up to 80% in animal models of a difficult-to-treat form of heart failure.
  • Urolithin A helped stiff heart tissue relax.
  • Urolithin A reduced scarring and abnormal enlargement in heart tissue.
  • Urolithin A improved relaxation in engineered human heart tissue.